Extended Donor Criteria Have No Negative Impact on Early Outcome After Liver Transplantation: A Single-Center Multivariate Analysis

Transplantation Proceedings

Volumn 39, Issue 2, 2007, Pages 529-534

  Schemmer, P ^a   Nickkholgh, A ^a   Hinz, U ^a   Gerling, T ^b   Mehrabi, A ^a   Sauer, P ^a   Encke, J ^a   Friess, H ^a   Weitz, J ^a   Buchler M W ^a   Schmidt, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; SODIUM ION;

ADOLESCENT; ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CADAVER DONOR; COLD ISCHEMIA; DONOR SELECTION; DRUG ABUSE; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; LENGTH OF STAY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; RISK ASSESSMENT; SAFETY; SCHOOL CHILD; SODIUM BLOOD LEVEL; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33847743818     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.12.002     Document Type: Article

References (24)

1. Starzl T.E. Back to the future. Transplantation 79 (2005) 1009
2. Moore D.E., Feurer I.D., Speroff T., et al. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 140 (2005) 273
3. Feierman D.E., and New York State Committee on Quality Improvement in Living Liver Donation. The growing field of anesthesia for liver transplantation. J Cardiothorac Vasc Anesth 18 (2004) 825
4. Steadman R.H. Anesthesia for liver transplant surgery. Anesthesiol Clin North Am 22 (2004) 687
5. Jain A., Marcos A., Reyes J., et al. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc 37 (2005) 1207
6. Klupp J., Pfitzmann R., Langrehr J.M., et al. Indications of mycophenolate mofetil in liver transplantation. Transplantation 80 (2005) S142
7. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network. Transplant Data: 1990-1999. Richmond, VA: UNOS; and Rockville, MD: Division of Transplantation, Bureau of Health Resources and Services Administration, US Department of Health and Human Services; 2000
8. Bundesärztekammer, Bekanntmachungen: Richtlinien zur Organtransplantation gemäβ § 16 TPG, PP 3, Ausgabe Mai 2004, Seite 246
9. Briceno J., Marchal T., Padillo J., et al. Influence of marginal donors on liver preservation injury. Transplantation 74 (2002) 522
10. Kniepeiss D., Iberer F., Grasser B., et al. A single-center experience with retrograde reperfusion in liver transplantation. Transpl Int 16 (2003) 730
11. Yersiz H., Shaked A., Olthoff K., et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 60 (1995) 790
12. Mirza D.F., Gunson B.K., Da Silva R.F., et al. Policies in Europe on "marginal quality" donor livers. Lancet 344 (1994) 1480
13. Sotiropoulos G.C., Paul A., Molmenti E., et al. Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants". Transplantation 80 (2005) 897
14. Renz J.F., Kin C., Kinkhabwala M., et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242 (2005) 556
15. Donataccio D., Roggen F., De Reyck C., et al. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool. Transpl Int 19 (2006) 38
16. Nashan B., Luck R., Becker T., et al. Expansion of the donor pool in liver transplantation: the Hannover experience 1996-2002. Clin Transpl (2002) 221
17. Pokorny H., Langer F., Herkner H., et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 19 (2005) 532
18. Briceno J., Solorzano G., and Pera C. A proposal for scoring marginal liver grafts. Transpl Int 13 Suppl 1 (2000) S249
19. Figueras J., Busquets J., Grande L., et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation: A multivariate analysis. Transplantation 61 (1996) 410
20. Markmann J.F., Markmann J.W., Markmann D.A., et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 72 (2001) 1113
21. Salizzoni M., Franchello A., and Zamboni F. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 16 (2003) 486
22. Jain A., Reyes J., Kashyap R., et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 232 (2000) 490
23. Levy M.F., Somasundar P.S., Jennings L.W., et al. The elderly liver transplant recipient: a call for caution. Ann Surg 233 (2001) 107
24. Showstack J., Katz P.P., Lake J.R., et al., NIDDK Liver Transplantation Database Group. Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. JAMA 281 (1999) 1381